Gloss AD, Vasso DG, Hailey AL, Nelson Dittrich AC, Schramm K, Reichelt M
The peptide is typically administered via subcutaneous injection, and therapy may consist of two short courses per year, following either the 100mg Russian Protocol or the 50mg Ukrainian Protocol
Clinically, this manifests as peripheral neuropathy, characterized by numbness, painful tingling, burning sensations in the extremities, and eventual loss of motor function
(3,4, 5) Supporting the Immune System
Animal studies report effects on tendon, ligament, and gastrointestinal tissue repair, but no Phase 3 human trials have been completed
NL-GHK-CU is the worlds first supplement containing TETRAPEPTIDE + Copper (Cu), synthesized using our patented NL-PEPTIDES technology, known as the new generation of peptides